|
1
|
Sangiovanni A, Del Ninno E, Fasani P, et
al: Increased survival of cirrhotic patients with a hepatocellular
carcinoma detected during surveillance. Gastroenterology.
126:1005–1014. 2004. View Article : Google Scholar
|
|
2
|
Cormier JN, Thomas KT, Chari RS, et al:
Management of hepatocellular carcinoma. J Gastrointest Surg.
10:761–780. 2006. View Article : Google Scholar
|
|
3
|
Pakin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
4
|
Llovert JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
|
|
5
|
No authors listed. Predictive factors for
long term prognosis after partial hepatectomy for patients with
hepatocellular carcinoma in Japan. The Liver Cancer Group of Japan.
Cancer. 74:2772–2780. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruix J and Sherman M; Practice Guidelines
Committee, American Association for the Study of Liver Diseases.
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar
|
|
7
|
Chirica M, Scatton O, Massault PP, et al:
Treatment of stage IVA hepatocellular carcinoma: should we
reappraise the role of surgery? Arch Surg. 143:538–543. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mazzaferro V, Regalia E, Doci R, et al:
Liver transplantation for the treatment of small hepatocellular
carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yanaga K: Current status of hepatic
resection for hepatocellular carcinoma. J Gastroenterol.
39:919–926. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou ZD, Tang ZY, Yang BH, et al:
Experience of 1000 patients who underwent hepatectomy for small
hepatocellular carcinoma. Cancer. 91:1479–1486. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazzaferro V, Chun YS, Poon RT, et al:
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol.
15:1001–1007. 2008. View Article : Google Scholar
|
|
12
|
Trevisani F, De Notariis S, Rossi C and
Bernardi M: Randomized control trials on chemoembolization for
hepatocellular carcinoma: Is there room for new studies? J Clin
Gastroenterol. 32:383–389. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hawkins MA and Dawson LA: Radiation
therapy for hepatocellular carcinoma: from palliation to cure.
Cancer. 106:1653–1663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng MB, Cui YL, Lu Y, et al:
Transcatheter arterial chemoembolization in combination with
radiotherapy for unresectable hepatocellular carcinoma: a
systematic review and meta-analysis. Radiother Oncol. 92:184–194.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren ZG, Zhao JD, Gu K, et al:
Three-dimensional conformal radiation therapy and
intensity-modulated radiation therapy combined with transcatheter
arterial chemoembolization for locally advanced hepatocellular
carcinoma: an irradiation dose escalation study. Int J Radiat Oncol
Biol Phys. 79:496–502. 2011. View Article : Google Scholar
|
|
16
|
Law AL, Ng WT, Lee MC, et al: Treatment of
primary liver cancer using highly-conformal radiotherapy with
kV-image guidance and respiratory control. Radiother Oncol.
102:56–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang ZX, Wang D, Wang G, et al: Clinical
study of recombinant adenovirus-p53 combined with fractionated
stereotactic radiotherapy for hepatocellular carcinoma. J Cancer
Res Clin Oncol. 136:625–630. 2010. View Article : Google Scholar
|
|
18
|
Price TR, Perkins SM, Sandrasegaran K, et
al: Evaluation of response after stereotactic body radiotherapy for
hepatocellular carcinoma. Cancer. 118:3191–3198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Son SH, Choi BO, Ryu MR, et al:
Stereotactic body radiotherapy for patients with unresectable
primary hepatocellular carcinoma: dose-volumetric parameters
predicting the hepatic complication. Int J Radiat Oncol Biol Phys.
78:1073–1080. 2010.PubMed/NCBI
|
|
20
|
Zhong NB, Chen ZH and LV GM: A clinical
study on stereotactic body radiotherapy for hepatocellular
carcinoma with portal vein tumor thrombosis. J Cancer Res Ther.
1:143–148. 2013. View Article : Google Scholar
|
|
21
|
WHO Handbook for Reporting Results of
Cancer Treatment. WHO Offset Publication No. 48. World Health
Organization; Geneva: 1979
|
|
22
|
Shah SA, Greig PD, Galllinger S, et al:
Factors associated with early recurrence after resection for
hepatocellular carcinoma and outcomes. J Am Coll Surg. 202:275–283.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Regimbeau JM, Abdalla Ek, Vauthey JN, et
al: Risk factors for early death due to recurrence after liver
resection for hepatocellular carcinoma: results of a multicenter
study. J Surg Oncol. 85:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeh CN, Lee WC and Chen MF: Hepatic
resection and prognosis for patients with hepatocellular carcinoma
larger than 10 cm: two decades of experience at Chang Gung memorial
hospital. Ann Surg Oncol. 10:1070–1076. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shah SA, Wei AC, Cleary SP, et al:
Prognosis and results after resection of very large (>or=10 cm)
hepatocellular carcinoma. J Gastrointest Surg. 11:589–595. 2007.
View Article : Google Scholar
|
|
26
|
Pawlik TM, Delman KA, Vauthey JN, et al:
Tumor size predicts vascular invasion and histologic grade:
Implications for selection of surgical treatment for hepatocellular
carcinoma. Liver Transpl. 11:1086–1092. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Llovet JM, Schwartz M and Mazzaferro V:
Resection and liver transplantation for hepatocellular carcinoma.
Semin Liver Dis. 25:181–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harada T, Matsuo K, Inoue T, et al: Is
preoperative hepatic arterial chemoembolization safe and effective
for hepatocellular carcinoma? Ann Surg. 224:4–9. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JK, Chung YH, Song BC, et al:
Recurrence of hepatocellular carcinoma following initial remission
by transcatheter arterial chemoembolization. J Gastroenterol
Hepatol. 17:52–58. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mok KT, Wang BW, Lo GH, et al:
Multimodality management of hepatocellular carcinoma larger than 10
cm. J Am Coll Surg. 197:730–738. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu TH, Yu MC, Chen TC, et al:
Encapsulation is a significant prognostic factor for better outcome
in large hepatocellular carcinoma. J Surg Oncol. 105:85–90. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ng KM, Yan TD, Black D, et al: Prognostic
determinants for survival after resection/ablation of a large
hepatocellular carcinoma. HPB (Oxford). 11:311–320. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen XP, Qiu FZ, Wu ZD, et al: Long-term
outcome of resection of large hepatocellular carcinoma. Br J Surg.
93:600–606. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Poon RT, Fan ST and Wong J: Selection
criteria for hepatic resection in patients with large
hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll
Surg. 194:592–602. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee MT, Kim JJ, Dinniwell R, et al: Phase
I study of individualized stereotactic body radiotherapy of liver
metastases. J Clin Oncol. 27:1585–1591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Toya R, Murakami R, Baba Y, et al:
Conformal radiotherapy for portal vein tumor thrombosis of
hepatocellular carcinoma. Radiother Oncol. 84:266–271. 2007.
View Article : Google Scholar : PubMed/NCBI
|
